- Home
- VYGR vs MNSB Comparison
VYGR vs MNSB Comparison
Compare VYGR & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- MNSB
- Stock Information
- Founded
- VYGR 2013
- MNSB 2003
- Country
- VYGR United States
- MNSB United States
- Employees
- VYGR N/A
- MNSB N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- MNSB Major Banks
- Sector
- VYGR Health Care
- MNSB Finance
- Exchange
- VYGR Nasdaq
- MNSB Nasdaq
- Market Cap
- VYGR 156.0M
- MNSB 140.7M
- IPO Year
- VYGR 2015
- MNSB N/A
- Fundamental
- Price
- VYGR $2.97
- MNSB $18.30
- Analyst Decision
- VYGR Strong Buy
- MNSB
- Analyst Count
- VYGR 8
- MNSB 0
- Target Price
- VYGR $14.33
- MNSB N/A
- AVG Volume (30 Days)
- VYGR 841.7K
- MNSB 23.4K
- Earning Date
- VYGR 08-05-2025
- MNSB 07-28-2025
- Dividend Yield
- VYGR N/A
- MNSB 2.17%
- EPS Growth
- VYGR N/A
- MNSB N/A
- EPS
- VYGR N/A
- MNSB N/A
- Revenue
- VYGR $66,958,000.00
- MNSB $59,896,000.00
- Revenue This Year
- VYGR N/A
- MNSB $17.95
- Revenue Next Year
- VYGR $78.88
- MNSB $2.52
- P/E Ratio
- VYGR N/A
- MNSB N/A
- Revenue Growth
- VYGR N/A
- MNSB N/A
- 52 Week Low
- VYGR $2.65
- MNSB $15.00
- 52 Week High
- VYGR $9.55
- MNSB $20.88
- Technical
- Relative Strength Index (RSI)
- VYGR 41.86
- MNSB 45.27
- Support Level
- VYGR $3.24
- MNSB $18.00
- Resistance Level
- VYGR $3.64
- MNSB $18.52
- Average True Range (ATR)
- VYGR 0.27
- MNSB 0.46
- MACD
- VYGR -0.02
- MNSB -0.07
- Stochastic Oscillator
- VYGR 6.17
- MNSB 24.65
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.